Ignite Creation Date:
2024-05-05 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00683111
Status:
COMPLETED
Last Update Posted:
2012-06-06
First Post:
2008-05-21
Brief Title:
Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
Sponsor:
Ruttonjee Hospital
Organization:
Ruttonjee Hospital
Study Overview
Official Title:
Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications in Patients With Acute Coronary Syndrome or Myocardial Infarction
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aspirin and clopidogrel - heparin or thrombolytic co-therapy is well established and effective treatment for unstable cardiac patients However the major complication was gastrointestinal bleeding GIB due to peptic ulcer In the prevention of GIB anti-ulcer drug either H2-receptor antagonist H2RA and proton pump inhibitor PPI were commonly prescribed There has been no prospective controlled study to compare the efficacy of these two classes of anti-ulcer drugs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None